Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results

TUCSON, Ariz., Jan. 10, 2025 /PRNewswire/ — Accelerate Diagnostics, Inc. (Nasdaq: AXDX) (Accelerate), an in vitro diagnostics company dedicated to providing services that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections, today…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.